Skip to main content
. 2013 Sep 30;54(5):1406–1417. doi: 10.1111/trf.12423

Table 3.

Common methods for virus inactivation*

Treatment Treatment conditions Advantages Limitations Relevant properties to be recorded
Pasteurization
  • Heat treatment in aqueous solution at 60°C for 10 hr

  • Stabilizers (sugars, amino acids, or acetate) added

  • Inactivates enveloped and some nonenveloped viruses, including HAV and B19V

  • Relatively simple equipment

  • Protein stabilizers may also stabilize viruses

  • Stabilizers usually need to be removed after process is completed

  • HBV is relatively heat stable

  • Process validation required

  • Temperature

  • Temperature homogeneity

  • Duration

  • Stabilizer concentration

Terminal dry heat
  • Heat treatment of lyophilized product at 80°C for 72 hr

or

  • Heat treatment of lyophilized product at 100°C for 30‐120 min
  • Inactivates enveloped and some nonenveloped viruses, including HAV

  • Treatment applied on final container

  • At least 80°C usually required for reduction of hepatitis viruses

  • Requires strict control of moisture content

  • Freezing and lyophilization and dry heat treatment conditions require extensive validation

  • Temperature

  • Temperature homogeneity

  • Duration

  • Moisture content

Vapor heat
  • Heat treatment of lyophilized product at 60°C for 10 hr, with water content adjusted to 7%‐8% (wt/wt)

  • Additional heating at 80°C for 1 hr for some products

  • Inactivates enveloped and some nonenveloped viruses, including HAV

  • Freezing and lyophilization and heating conditions require extensive validation

  • Temperature

  • Temperature homogeneity

  • Duration

  • Moisture during heating

S/D
  • Typical conditions: 0.3% TNBP and 1% nonionic detergent, either Tween 80 (≥6 hr) or Triton X‐100 (≥4 hr) at 24°C

  • Very efficient against enveloped viruses

  • Does not denature proteins

  • High process recovery

  • Relatively simple equipment

  • Not generally affected by buffers

  • Nonenveloped viruses unaffected

  • S/D reagents must be removed

  • Temperature

  • Duration

  • Reagent concentration

  • Lipid levels must be controlled

  • In‐process solution free from gross aggregates potentially protecting viruses

* Adapted from the World Health Organization.13

TNBP = tri(n‐butyl)phosphate.